- €17.91bn
- €25.45bn
- €58.95bn
- 50
- 94
- 97
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49,328 | 33,282 | 49,745 | 75,153 | 58,948 |
Cost of Revenue | |||||
Gross Profit | 11,648 | 7,267 | 12,287 | 18,712 | 15,141 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52,573 | 35,779 | 45,961 | 69,244 | 54,768 |
Operating Profit | -3,245 | -2,497 | 3,784 | 5,909 | 4,180 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3,201 | -3,304 | 4,329 | 7,180 | 4,365 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3,789 | -3,320 | 2,528 | 4,345 | 3,284 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3,816 | -3,289 | 2,499 | 4,251 | 3,168 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3,845 | -3,343 | 2,439 | 4,191 | 3,108 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.298 | -0.715 | 2.49 | 4.76 | 3.52 |
Dividends per Share |